Pluri Inc. Cash Equivalents, at Carrying Value
Pluri Inc. (PLUR) had Cash Equivalents, at Carrying Value of $3.53 million as of 2026-06-30, per its 10-K filed 2026-09-10.
Financial Statements › Balance Sheet › Assets › Assets, Current › Cash, Cash Equivalents, and Short-Term Investments › Cash and Cash Equivalent
us-gaap:CashEquivalentsAtCarryingValue · last filed 2026-09-10
- 2026-06-30: Cash Equivalents, at Carrying Value $3.53M.
- 2026-03-31: Cash Equivalents, at Carrying Value $3.42M.
- 2025-12-31: Cash Equivalents, at Carrying Value $4.69M.
- 2025-09-30: Cash Equivalents, at Carrying Value $4.26M.
| Period end | Cash Equivalents, at Carrying Value |
|---|---|
| 2026-06-30 | $3.53M 10-K · filed 2026-09-10 |
| 2026-03-31 | $3.42M 10-Q · filed 2026-05-14 |
| 2025-12-31 | $4.69M 10-Q · filed 2026-02-12 |
| 2025-09-30 | $4.26M 10-Q · filed 2025-11-12 |
| 2025-06-30 | $5.89M 10-K · filed 2026-09-10 |
| 2025-03-31 | $8.50M 10-Q · filed 2026-05-14 |
| 2024-12-31 | $7.23M 10-Q · filed 2026-02-12 |
| 2024-09-30 | $3.20M 10-Q · filed 2025-11-12 |
| 2024-06-30 | $6.78M 10-K · filed 2025-09-17 |
| 2024-03-31 | $7.08M 10-Q · filed 2025-05-13 |
| 2023-12-31 | $5.47M 10-Q · filed 2025-02-11 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| INTENSITY THERAPEUTICS, INC. (INTS) | United States | $0.013B | -1.08 |
| BRAINSTORM CELL THERAPEUTICS INC. (BCLI) | United States | $0.013B | -1.05 |
| Passage BIO, Inc. (PASG) | United States | $0.015B | -0.43 |
| IN8BIO, INC. (INAB) | United States | $0.012B | -0.76 |
| DYADIC INTERNATIONAL INC (DYAI) | United States | $0.016B | |
| BioCardia, Inc. (BCDA) | United States | $0.016B | |
| Senti Biosciences Holdings, Inc. (SNTI) | United States | $0.011B | -0.70 |
| TScan Therapeutics, Inc. (TCRX) | United States | $0.008B | -1.23 |
| Jasper Therapeutics, Inc. (JSPR) | United States | $0.020B | -0.37 |
| CERO THERAPEUTICS HOLDINGS, INC. (CERO) | United States | $0.007B |